Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trialDaniel Catovsky, Peter Hillmen, Estella Matutes et al.|The Lancet|2007Cited by 679
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLLAndreas Agathangelidis, Arnon P. Kater, Anastasia Chatzidimitriou et al.|Blood|2020Cited by 132
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONYLarry Mansouri, María José Terol, Silvia Bonfiglio et al.|Leukemia|2022Cited by 55
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONYThomas Chatzikonstantinou, Elżbieta Kalicińska, Lydia Scarfò et al.|EClinicalMedicine|2023Cited by 21
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarkerBirna Þorvaldsdóttir, Richard Rosenquist, Larry Mansouri et al.|Leukemia|2025Cited by 5